Pharmaceutical giant Pfizer is set to create over 400 jobs at a new manufacturing plant in Dublin.
The company announced that it will invest €1.2 billion in the construction and development of a new manufacturing plant at its Grange Castle site in Clondalkin, Dublin. Pfizer currently employs 5,000 people in Ireland with facilities in Dublin, Kildare, and Cork.
The announcement follows a €40 million investment in the site last year, when the Dublin facility was brought onto the global Pfizer Covid-19 manufacturing network. The planned new manufacturing plant at Grange Castle is expected to double the capacity for biological drug substance manufacturing.
Read more: HSE warns of early flu season as cases shoot up among children
Construction works on the facility are expected to begin in 2024, with the new facility due for completion in 2027. Mike McDermott, Pfizer's chief global supply officer, said Grange Castle has played an important role in the company's global Covid-19 vaccine network.
He said: "We are very pleased about today's announcement, as it significantly strengthens our operations in Ireland, where we have three high-performing and strategic manufacturing sites.
He added: "Grange Castle has played a critical role in our global Covid-19 vaccine network, and this investment for non-Covid licensed and pipeline products, will help to further expand the site’s broad and robust capabilities."
Pfizer has operated in Ireland for over 50 years, becoming one of the first pharmaceutical companies to come here in 1969.
READ NEXT:
- Christmas jobs: The Dublin businesses hiring part-time workers for festive season
- Hewlett Packard announces major job losses
- Amazon expected to announce job cuts worldwide with future for Ireland unknown
- Twitter layoffs: Firm accused of 'actively ignoring Irish labour laws'
- Popular wedding venue Finnstown Castle Hotel to cease trading under current operator
Sign up to the Dublin Live Newsletter to get all the latest Dublin news straight to your inbox.
